SST Corporation - Home



USV offers R&D and manufacturing capabilities in APIs and intermediates in finished dosage forms and is recognized as the world’s leading producer of metformin HCl.

FDA Status
FDA Inspected

Therapeutic Classes
APIs: anti-diabetes, cardiovascular, oncology, CNS and ophthalmology.
Finished Dosage: anti-diabetes, cardiovascular and nutritional.

Facilities / Capabilities
R&D capabilities include lab scale, kilo for producing quantities from 1 to 5 kilos and pilot plant facility for producing quantities from 5 to 25 kilos. Pilot plant has 21 reactors with capacities ranging from 100 liters to 1,600 liters with both SS and glass reactors. A separate area is being created for specialty products.

APIs: Dedicated facilities for metformin and glipizide. Dedicated equipment for glyburide. Multipurpose manufacturing facility for APIs.
Finished Dosage: Has a newly built finished dosage facility designed to meet FDA standards and approved by European authorities for oral solid dosage.

SST has prided itself on its customer service for more than 50 years, bringing unparalleled reassurance and added value.
SST offers fine chemicals and intermediates (FCIs) through its global supplier network.
Learn more.
For more information on SST products and services, email us or call 844.476.8200.
© 2010 SST CORPORATION        Privacy / Terms of Use        Site